{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:37:14Z","timestamp":1788349034377,"version":"build-2803163510"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"vor","delay-in-days":1557,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p>The tolerability of dapoxetine, a short\u2010acting selective serotonin reuptake inhibitor being developed for premature ejaculation, was evaluated when coadministered with tamsulosin. Adult men on a stable dose of tamsulosin were randomized to also receive dapoxetine 30 or 60 mg, or placebo, in a crossover design. Supine and standing vital signs were measured on days 1 and 7. Plasma samples were collected for measurement of tamsulosin, dapoxetine, and dapoxetine metabolites. Coadministration of dapoxetine with tamsulosin did not alter orthostatic profiles or affect the incidence of orthostatic hypotension. Tamsulosin and dapoxetine pharmacokinetics were not altered. Adverse events were reported by 5.4%, 10.9%, and 23.2% of participants receiving tamsulosin with placebo, dapoxetine 30 mg, and dapoxetine 60 mg, respectively. The most common adverse events were diarrhea, dizziness, headache, and nausea. Therefore, dapoxetine had no clinically important effects on the pharmacokinetics or orthostatic profile of tamsulosin in men on a stable tamsulosin regimen.<\/jats:p>","DOI":"10.1177\/0091270008324695","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T00:33:47Z","timestamp":1222994027000},"page":"1438-1450","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Dapoxetine on the Pharmacokinetics and Hemodynamic Effects of Tamsulosin in Men on a Stable Dose of Tamsulosin"],"prefix":"10.1002","volume":"48","author":[{"given":"N. B.","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901250"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.07.004"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(97)00183-6"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000132159.61156.ea"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69373-2"},{"key":"e_1_2_5_8_2","unstructured":"KaufmanJ RosenRC RowlandDL MudumbiR TesfayeF RothmanM.Improved distress related to ejaculation in men with premature ejaculation (PE) who responded to dapoxetine. Poster presented at: Annual Meeting of the American Urological Association; May 19\u201324 2007; Anaheim California."},{"key":"e_1_2_5_9_2","unstructured":"BuvatJ GiulianoF TesfayeF RothmanM RivasD.Efficacy and safety of dapoxetine for premature ejaculation (PE): results from a placebo\u2010controlled double\u2010blind randomized parallel\u2010group study in 22 countries. Oral presentation at: 27th Annual Meeting of the Societe Internationale d'Urologie; September 2\u20136 2007; Paris France."},{"key":"e_1_2_5_10_2","unstructured":"McMahonC ParkNC ZhaoY RothmanM RivasD.Treatment of premature ejaculation (PE) in the Asia\u2010Pacific region: results from a phase III double\u2010blind parallel\u2010group study of dapoxetine. Oral presentation at: 11th Biennial Meeting of the Asia Pacific Society for Sexual Medicine; October 6\u201310 2007; Jeju Korea. Abstract OS05_06."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005284850"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006291033"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052284"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-8673.1996.tb00352.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000097026.43866.cc"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219020-00004"},{"key":"e_1_2_5_17_2","article-title":"Tamsulosin for benign prostatic hyperplasia","author":"Wilt TJ","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_18_2","unstructured":"ModiNB NathR WangB RivasD GuptaS.Dapoxetine has no effects on hemodynamics or electrocardiographic assessments. Presented at: 10th Congress of the European Society for Sexual Medicine; November 25\u201328 2007; Lisbon Portugal."},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta\u2010analysis on the efficacy and tolerability of alpha1\u2010adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction","volume":"36","author":"Djavan B","year":"1999","journal-title":"Eur Urol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050477"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/004982598238985"},{"key":"e_1_2_5_22_2","volume-title":"National High Blood Pressure Education Program: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","year":"2004"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270008324695","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0091270008324695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T21:55:15Z","timestamp":1697147715000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/0091270008324695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1177\/0091270008324695"],"URL":"https:\/\/doi.org\/10.1177\/0091270008324695","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}